Cargando…

A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma

Accurate classification of squamous cell carcinoma (SCC) from adenocarcinoma (AC) of non–small cell lung cancer (NSCLC) can lead to personalized treatments of lung cancer. We aimed to develop a miRNA-based prediction model for differentiating SCC from AC in surgical resected tissues and bronchoalveo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hui, Jiang, Zhengran, Leng, Qixin, Bai, Fan, Wang, Juan, Ding, Xiaosong, Li, Yuehong, Zhang, Xianghong, Fang, HongBin, Yfantis, Harris G, Xing, Lingxiao, Jiang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584193/ https://www.ncbi.nlm.nih.gov/pubmed/28881596 http://dx.doi.org/10.18632/oncotarget.17038

Ejemplares similares

Long non-coding RNA FEZF1-AS1 facilitates non-small cell lung cancer progression via the ITGA11/miR-516b-5p axis
por: Song, Heng, et al.
Publicado: (2020)

Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Dong, Yanting, et al.
Publicado: (2020)

MicroRNA‐153‐3p regulates cell proliferation and cisplatin resistance via Nrf‐2 in esophageal squamous cell carcinoma
por: Zuo, Jing, et al.
Publicado: (2020)

Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma
por: Xiao, Jian, et al.
Publicado: (2017)

Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis
por: Huang, Tao, et al.
Publicado: (2016)

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011)

The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung
por: Galindo, Inmaculada, et al.
Publicado: (2019)

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer
por: Su, Jian, et al.
Publicado: (2018)

A plasma miRNA signature for lung cancer early detection
por: Leng, Qixin, et al.
Publicado: (2017)

Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile
por: Yamashita, Takashi, et al.
Publicado: (2023)

MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung
por: Mawas, Amany Sayed, et al.
Publicado: (2018)

Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Xiao-Nan, et al.
Publicado: (2015)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Feng, et al.
Publicado: (2021)

Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma
por: Li, Fangfang, et al.
Publicado: (2022)

Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
por: Han, Xiangkun, et al.
Publicado: (2014)

Development and validation of a radiomic nomogram based on pretherapy dual-energy CT for distinguishing adenocarcinoma from squamous cell carcinoma of the lung
por: Chen, Zhiyong, et al.
Publicado: (2022)

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer
por: Zuo, Ying, et al.
Publicado: (2022)

Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer
por: Pang, Wenshuai, et al.
Publicado: (2014)

Value of contrast-enhanced magnetic resonance imaging-T2WI-based radiomic features in distinguishing lung adenocarcinoma from lung squamous cell carcinoma with solid components >8 mm
por: Yang, Maoyuan, et al.
Publicado: (2023)

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)

Author Correction: Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
por: Han, Xiangkun, et al.
Publicado: (2022)

Factors distinguishing invasive from pre-invasive adenocarcinoma presenting as pure ground glass pulmonary nodules
por: Yang, Huan-Huan, et al.
Publicado: (2020)

A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer
por: Leng, Qixin, et al.
Publicado: (2018)

The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
por: JIANG, Binghu, et al.
Publicado: (2013)

Correction to: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
por: Ning, Jing, et al.
Publicado: (2021)

The High Diagnostic Accuracy of Combined Test of Thyroid Transcription Factor 1 and Napsin A to Distinguish between Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta-Analysis
por: Li, Li, et al.
Publicado: (2014)

Inflammation-mediated SOD-2 upregulation contributes to epithelial-mesenchymal transition and migration of tumor cells in aflatoxin G(1)-induced lung adenocarcinoma
por: Yi, Li, et al.
Publicado: (2017)

Comparison of Comprehensive Morphological and Radiomics Features of Subsolid Pulmonary Nodules to Distinguish Minimally Invasive Adenocarcinomas and Invasive Adenocarcinomas in CT Scan
por: Qiu, Lu, et al.
Publicado: (2022)

An integromic signature for lung cancer early detection
por: Leng, Qixin, et al.
Publicado: (2018)

Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact
por: Jiang, Yining, et al.
Publicado: (2021)

Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma
por: Keyhanian, Kianoosh, et al.
Publicado: (2022)

Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks
por: Kim, Nah Ihm, et al.
Publicado: (2020)

A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer
por: Lin, Yanli, et al.
Publicado: (2018)

An Immune-Related Genetic Feature Depicted the Heterogeneous Nature of Lung Adenocarcinoma and Squamous Cell Carcinoma and Their Distinctive Predicted Drug Responses
por: Li, Qiuyuan, et al.
Publicado: (2022)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA‐96
por: Zhang, Yufeng, et al.
Publicado: (2019)

Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma
por: Pan, Meini, et al.
Publicado: (2023)

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status
por: Li, Hongwei, et al.
Publicado: (2017)

Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma
por: Xu, Bin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g3mvpls3ucmdvk9rh6510gn7q5